
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
SML Mahindra Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Ambition to create a INR 12,500 crore business by FY31 with growth in market share but no direct mention of capex or new facility timelines. Key concall…
25 Sept 2026
SML Mahindra Q3 FY17 earnings call: Revenue & Margins | Arthneeti
Q3 FY17
228.12 crores in Dec'16 quarter compared to Rs. Key concall takeaways from SML Mahindra Ltd's Q3 FY17 earnings call — and how it ranks against sector peers.
25 Sept 2026
SML Mahindra Q4 FY17 earnings call: Revenue & Margins | Arthneeti
Q4 FY17
371.13 crores (Page 27). Key concall takeaways from SML Mahindra Ltd's Q4 FY17 earnings call — and how it ranks against sector peers.
25 Sept 2026
Procter & Gamble Health Q2 FY23 earnings call: Revenue & Margins | Arthneeti
Q2 FY23
The content mostly covers: . Key concall takeaways from Procter & Gamble Health Ltd's Q2 FY23 earnings call — and how it ranks against sector peers.
25 Sept 2026
SML Mahindra Q1 FY18 earnings call: Revenue & Margins | Arthneeti
Q1 FY18
357.54 crores (down from Rs. Key concall takeaways from SML Mahindra Ltd's Q1 FY18 earnings call — and how it ranks against sector peers.
25 Sept 2026
Procter & Gamble Health Q2 FY24: Revenue ₹1230 Cr, PAT ₹229 Cr | Arthneeti
Q2 FY24
Reported revenue: ₹1230 crore (page 17) . Key concall takeaways from Procter & Gamble Health Ltd's Q2 FY24 earnings call — and how it ranks against sector…
25 Sept 2026
Procter & Gamble Health Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
FY 2025-26 sales grew by +16% year-on-year, indicating strong consistent balanced growth (Page 8). Key concall takeaways from Procter & Gamble Health Ltd's Q1…
25 Sept 2026
Procter & Gamble Health Q4 FY18 earnings call: Revenue & Margins | Arthneeti
Q4 FY18
BPL Business revenue (FY ended 31 Dec 2017): INR 3,734 million (35% of total company revenue) . Key concall takeaways from Procter & Gamble Health Ltd's Q4…
25 Sept 2026
Powergrid Infrastructure Investment Trust Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
Total Income (Revenue) for Q1FY25 reported at ₹3,266.80 million (Page 8). Key concall takeaways from Powergrid Infrastructure Investment Trust's Q1 FY25…
25 Sept 2026
Powergrid Infrastructure Investment Trust Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Total Income for Q3FY25: ₹3,292 million (Page 8). Key concall takeaways from Powergrid Infrastructure Investment Trust's Q3 FY25 earnings call — and how it…
25 Sept 2026
Kennametal India Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Q4 FY26 Sales: $737 million, a 43% increase vs. Key concall takeaways from Kennametal India Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
25 Sept 2026
SG Mart Q4 FY24 earnings call: Revenue & Margins | Arthneeti
Q4 FY24
Q4 FY24 Revenue:** ₹12,775 million (Rs 12.775 billion) . Key concall takeaways from SG Mart Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.
25 Sept 2026
Genus Power Infrastructures Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Q1FY27 revenue: INR 1,364.9 crore, up 44.8% YoY from INR 942.4 crore in Q1FY26. Key concall takeaways from Genus Power Infrastructures Ltd's Q1 FY27 earnings…
25 Sept 2026
Authum Investment & Infrastructure Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
2,982.9 Cr (includes Investment Income Rs. Key concall takeaways from Authum Investment & Infrastructure Ltd's Q3 FY25 earnings call — and how it ranks against…
25 Sept 2026
Authum Investment & Infrastructure Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
4,322.1 Cr, slightly down from Rs. Key concall takeaways from Authum Investment & Infrastructure Ltd's Q4 FY25 earnings call — and how it ranks against sector…
25 Sept 2026
Authum Investment & Infrastructure Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
1,206.4 Cr (total income) . Key concall takeaways from Authum Investment & Infrastructure Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
25 Sept 2026
Authum Investment & Infrastructure Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
629.1 Cr vs. Key concall takeaways from Authum Investment & Infrastructure Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
25 Sept 2026
Authum Investment & Infrastructure Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
422.2 Cr, down from Rs. Key concall takeaways from Authum Investment & Infrastructure Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
25 Sept 2026
Maharashtra Seamless Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
1,091 crore from operations (Page 7) . Key concall takeaways from Maharashtra Seamless Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
25 Sept 2026
Suven Life Sciences Q1 FY22 earnings call: Revenue & Margins | Arthneeti
Q1 FY22
The provided pages of the Suven Life Sciences investor presentation do not contain any specific revenue, sales, or volume figures for any quarter. Key concall…
25 Sept 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access